Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Neurogenesis and Regeneration of Nervous Tissue01:15

Neurogenesis and Regeneration of Nervous Tissue

In the CNS, neurogenesis, the birth of new neurons from stem cells, is limited to the hippocampus in adults. In other regions of the brain and spinal cord, neurogenesis is almost non-existent due to inhibitory influences from neuroglia, especially oligodendrocytes, and the absence of growth-stimulating cues. The myelin produced by oligodendrocytes in the CNS inhibits neuronal regeneration. Furthermore, astrocytes proliferate rapidly after neuronal damage, forming scar tissue that physically...
Neuroplasticity01:01

Neuroplasticity

Neuroplasticity reflects the brain's remarkable capacity to adapt and evolve, responding dynamically to learning, experiences, or injury by reorganizing its neural circuitry. This reorganization involves creating new neural connections and refining old ones through a series of biological processes that contribute to the brain's lifelong development and adaptability.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Corrigendum to "Animal models of Huntington's disease. Pros and cons" [Brain, Behavior, Immunity Health 50 (2025) 101149.

Brain, behavior, & immunity - health·2026
Same author

Elevated MANF expression in β cells protects mice from streptozotocin-induced diabetes by attenuating islet stress and immunogenicity.

Molecular therapy : the journal of the American Society of Gene Therapy·2026
Same author

Animal models of Huntington's disease. Pros and cons.

Brain, behavior, & immunity - health·2025
Same author

Alcohol Facilitates Social Dominance Via Activating Dopamine 1 Receptor-expressing Neurons in the Lateral Septum of Male Mice.

Molecular neurobiology·2025
Same author

Modulation of the unfolded protein response with a C-terminal fragment of MANF facilitates recovery in models of multiple sclerosis.

Molecular therapy : the journal of the American Society of Gene Therapy·2025
Same author

DDHD2 provides a flux of saturated fatty acids for neuronal energy and function.

Nature metabolism·2025

Related Experiment Video

Updated: May 26, 2026

Anatomically Inspired Three-dimensional Micro-tissue Engineered Neural Networks for Nervous System Reconstruction, Modulation, and Modeling
10:45

Anatomically Inspired Three-dimensional Micro-tissue Engineered Neural Networks for Nervous System Reconstruction, Modulation, and Modeling

Published on: May 31, 2017

Neurorestoration.

Mikko Airavaara1, Merja H Voutilainen, Yun Wang

  • 1Institute of Biotechnology, University of Helsinki, Finland.

Parkinsonism & Related Disorders
|December 15, 2011
PubMed
Summary
This summary is machine-generated.

Neurotrophic factors like GDNF, MANF, and CDNF show promise for treating Parkinson's disease (PD) by protecting and regenerating midbrain dopamine neurons. These proteins offer potential therapeutic strategies for neurorestoration in PD patients.

More Related Videos

Synergetic Use of Neural Precursor Cells and Self-assembling Peptides in Experimental Cervical Spinal Cord Injury
11:57

Synergetic Use of Neural Precursor Cells and Self-assembling Peptides in Experimental Cervical Spinal Cord Injury

Published on: February 23, 2015

Perspectives on Neuroscience
26:41

Perspectives on Neuroscience

Published on: July 31, 2007

Related Experiment Videos

Last Updated: May 26, 2026

Anatomically Inspired Three-dimensional Micro-tissue Engineered Neural Networks for Nervous System Reconstruction, Modulation, and Modeling
10:45

Anatomically Inspired Three-dimensional Micro-tissue Engineered Neural Networks for Nervous System Reconstruction, Modulation, and Modeling

Published on: May 31, 2017

Synergetic Use of Neural Precursor Cells and Self-assembling Peptides in Experimental Cervical Spinal Cord Injury
11:57

Synergetic Use of Neural Precursor Cells and Self-assembling Peptides in Experimental Cervical Spinal Cord Injury

Published on: February 23, 2015

Perspectives on Neuroscience
26:41

Perspectives on Neuroscience

Published on: July 31, 2007

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Pharmacology

Background:

  • Trophic proteins, initially studied for neural development, exhibit neuroprotective and neuroregenerative effects in the adult central nervous system.
  • Midbrain dopamine neurons (MDN) are crucial in Parkinson's disease (PD), where they initially lose phenotype rather than undergo cell death, suggesting potential for neurorestoration.

Purpose of the Study:

  • To review the neurotrophic properties of TGF-β superfamily proteins for midbrain dopamine neurons (MDN).
  • To describe recent studies on novel trophic proteins MANF and CDNF for MDN.
  • To present data from animal models of PD on the therapeutic potential of these factors and small molecules.

Main Methods:

  • Review of existing literature on glial cell-derived neurotrophic factor (GDNF), neurturin, and bone morphogenetic proteins (BMPs).
  • Analysis of studies involving the newly identified trophic proteins MANF and CDNF.
  • Examination of data from animal models of Parkinson's disease.

Main Results:

  • Several trophic proteins, including GDNF, neurturin, BMPs, MANF, and CDNF, demonstrate trophic effects on MDN.
  • Animal models of PD suggest that these trophic proteins can promote neuroprotection and neuroregeneration.
  • Small molecules like AP(4)A, retinoic acid, and vitamin D(3) also exhibit neuroprotective properties.

Conclusions:

  • Trophic proteins and certain small molecules hold significant potential for developing novel therapeutics for Parkinson's disease.
  • Targeting MDN with these agents may offer a viable strategy for neurorestoration in PD.
  • Further research and clinical trials are warranted to translate these findings into human therapies.